Inclusion Check-in: Are Integrative Practices in New Federal Opioid Legislation, National Academy, and FDA Activity?
One can easily count the chickens of non-pharmacological approaches highlighted in multiple organizational guidelines and state strategies related to pain and opioids. But one definitely cannot count on them hatching inside each new, significant policy initiative. Regular medicine tends to regress toward a non-inclusive mean in pain treatment. And “mean”Read